MedPath

Phase I study of Multiple-Vaccine Therapy in Patient with Refractory Breast Cancer to Chemotherapy.

Phase 1
Recruiting
Conditions
Breast Cancer
Registration Number
JPRN-UMIN000002408
Lead Sponsor
Department of Breast and Endocrine Surgery, Juntendo University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
6
Inclusion Criteria

Not provided

Exclusion Criteria

1.No uncontrollable infections 2.No curative traumatic wound 3.No uncontrollable ulcera 4.No abnormal coagulation 5.Concurrent treatment with acetylsalicylic acid and/or NSAIDs 6.No thrombosis 7.No severe complications (heart failure etc) 8.No other malignancy requiring treatment 9.Concurrent treatment with steroids or immunosuppressing agent 10.No Psychosis 11.Pregnancy/Breast feeding 12.Decision of unsuitableness by principal investigator or physician in change

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
Âİ Copyright 2025. All Rights Reserved by MedPath